Development of a Methodology to Design a High Order Sliding Mode Controller for Drug Dosage
NCT ID: NCT02864212
Last Updated: 2020-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2014-09-30
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine in IVRA
NCT05123170
Hemodynamic and Cardiac Effects of Dexmedetomidine Versus Fentanyl by Intravenous Infusion as Adjuncts to General Anesthesia in Patients Undergoing Major Abdominal Cancer Surgeries.
NCT07214714
Preemptive Analgesia Of Dexmedetomidine Reduces Per-operation Pain
NCT06671327
Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia
NCT02141412
Intranasal Versus Intravenous Drug in Painful Procedure for Outpatient Oncologic Participants
NCT04621110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The observed drugs in this study are fast acting insulin, propofol and sodium nitroprusside.
The effect of insulin will be measured by a continuous glucose monitor, the effect of propofol by a bispectral index monitor and the the effect of sodium nitroprusside by a invasive blood pressure monitor.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glucose monitoring
Glucose will be monitor in patients using fast-acting insulin.
No interventions assigned to this group
Depth of anesthesia monitoring
Depth of anesthesia will be monitor in patients undergoing cardiac surgery.
No interventions assigned to this group
Blood pressure monitoring
Invasive blood pressure will be monitor in patients undergoing cardiac surgery.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coordinación de Investigación en Salud, Mexico
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana Gallardo, Dr
Role: PRINCIPAL_INVESTIGATOR
Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unidad de Investigación Médica en Enfermedades Metabólicas IMSS
Mexico City, Mexico City, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R-2014-785-063
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.